NCT06244407View on ClinicalTrials.gov

The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 23, 2024

Primary Completion Date

May 25, 2024

Study Completion Date

June 2, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

Vildagliptin and Metformin Hydrochloride 50mg 1000 mg Film-coated Tablets

Vildagliptin and Metformin Hydrochloride 50/1000 mg Film-coated Tablets

Sponsors
All Listed Sponsors
lead

International Bio service

NETWORK

NCT06244407 - The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions | Biotech Hunter | Biotech Hunter